Effect of clozapine on motor function in schizophrenic patients

被引:0
|
作者
Vrtunski, PB [1 ]
Konicki, PE [1 ]
Kwon, KY [1 ]
Jaskiw, GJ [1 ]
Jaskiw, GE [1 ]
机构
[1] CASE WESTERN RESERVE UNIV, SCH MED, BRECKSVILLE, OH 44141 USA
关键词
schizophrenia; motor function impairment; force control; atypical antipsychotic drug; clozapine;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
It is well established that clozapine is less likely than typical antipsychotic drugs to cause clinically discernible extrapyramidal side-effects. There is a paucity of data, however, on clozapine's motor effects. In this report we compare normal controls to groups of chronic schizophrenic patients treated with either typical antipsychotic drugs or with clozapine. Motor function was measured with a target-matching task, a test relying on submaximal sustained force control. Results indicated that patients on clozapine performed with significantly lower accuracy (greater variability) of force control. Even though the clozapine patients were treatment resistant to typical antipsychotic drugs, and many had a history of tardive dyskinesia, we postulate that the observed deficit is likely due to clozapine treatment rather than to earlier treatments or other factors. The observed force control deficit may be the result of an increase in myoclonus and a generally lower level of overall motor activity.
引用
收藏
页码:187 / 198
页数:12
相关论文
共 50 条
  • [31] The effects of clozapine on aggression and substance abuse in schizophrenic patients
    Volavka, J
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 : 43 - 46
  • [32] Hospitalizations and compliance among schizophrenic patients in treatment with clozapine
    Doll, A.
    Mena, A.
    Domato, M.
    EUROPEAN PSYCHIATRY, 2008, 23 : S157 - S158
  • [33] The effects of clozapine on plasma norepinephrine kinetics in schizophrenic patients
    Elman, I
    Goldstein, DS
    Holmes, C
    Adler, C
    Pickar, D
    Breier, A
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 214 - 214
  • [34] Concentrations in plasma clozapine levels in schizophrenic and schizoaffective patients
    Iglesias Garcia, Celso
    Iglesias Alonso, Ana
    Bobes, Julio
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2017, 10 (04): : 192 - 196
  • [35] A bioequivalence study of generic and brand clozapine in schizophrenic patients
    Sramek, JJ
    Anand, R
    Hartman, R
    Cutler, NR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PI90 - PI90
  • [36] Acute tryptophan depletion in schizophrenic patients treated with clozapine
    George, TP
    Potenza, MN
    Degen, K
    Sernyak, MJ
    Woods, S
    McDougle, CJ
    ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (03) : 291 - 292
  • [37] Substance abuse in clozapine-treated schizophrenic patients
    Sand, PG
    Soyka, M
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1997, 9 (04) : 626 - 627
  • [38] Neuropsychological assessment in schizophrenic patients treated with haloperidol or clozapine
    Citak, Serhat
    Cakici, Ebru T.
    Cakici, Mehmet
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 19 (01): : 5 - 14
  • [39] Clozapine as a treatment tool: only in resistant schizophrenic patients?
    Cassano, GB
    Ciapparelli, A
    Villa, M
    EUROPEAN PSYCHIATRY, 1997, 12 : 347S - 351S
  • [40] EFFICACY OF CLOZAPINE IN THE TREATMENT OF SCHIZOPHRENIC PATIENTS: A SYSTEMATIC REVIEW
    Alshehri, Asmaa Mesfer
    Bosi, Lamis Hisham
    Alshahrany, Afnan Muslah
    Alreemi, Yahya Mohammed
    Balosh, Ahmad Mahmmod
    Meshawi, Eman Abdulla
    Almhgany, Eman Ayed
    Alshahrany, Khadejah Mohammad
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (01): : 760 - 772